Spyre Therapeutics Return on Net Operating Assets Analysis

Spyre Therapeutics, Inc. (SYRE)

74.32 +2.40 (+3.34%) USD | NASDAQ | May 21, 16:00

74.32 0.00 (0.00%) After-Hours: 19:59

View Return on Net Operating Assets for SYRE.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Return on Net Operating Assets Chart

Start Trial

View Historical Data

Start Trial

View Return on Net Operating Assets Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Return on Net Operating Assets Benchmarks

Start Trial

Tyra Biosciences, Inc.	Upgrade
Revolution Medicines, Inc.	Upgrade
Apellis Pharmaceuticals, Inc.	Upgrade
Replimune Group, Inc.	Upgrade
Savara, Inc.	Upgrade